227 related articles for article (PubMed ID: 30439627)
1. Opioid responsiveness of nociceptive versus mixed pain in clinical cancer patients.
Bechakra M; Moerdijk F; van Rosmalen J; Koch BCP; van der Rijt CCD; Sillevis Smitt PAE; Jongen JLM
Eur J Cancer; 2018 Dec; 105():79-87. PubMed ID: 30439627
[TBL] [Abstract][Full Text] [Related]
2. A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients.
Nosek K; Leppert W; Nosek H; Wordliczek J; Onichimowski D
Drug Des Devel Ther; 2017; 11():2409-2419. PubMed ID: 28860712
[TBL] [Abstract][Full Text] [Related]
3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
4. The Association between Patient Characteristics and Opioid Treatment Response in Neuropathic and Nociceptive Pain due to Cancer.
Haumann J; van Kuijk SMJ; Joosten EA; van den Beuken-van Everdingen MHJ
J Palliat Med; 2019 Feb; 22(2):157-163. PubMed ID: 30359202
[TBL] [Abstract][Full Text] [Related]
5. Indication of Adequate Transdermal Fentanyl Dose in Opioid Switching From Oral Oxycodone in Patients With Cancer.
Matsumura C; Yamada M; Fujihara S; Chisaki Y; Takahashi K; Yano Y
Am J Hosp Palliat Care; 2016 Mar; 33(2):109-14. PubMed ID: 25324418
[TBL] [Abstract][Full Text] [Related]
6. Oxycodone, fentanyl, and morphine amplify established neuropathic pain in male rats.
Green-Fulgham SM; Ball JB; Kwilasz AJ; Fabisiak T; Maier SF; Watkins LR; Grace PM
Pain; 2019 Nov; 160(11):2634-2640. PubMed ID: 31299018
[TBL] [Abstract][Full Text] [Related]
7. Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone.
Takemura M; Niki K; Okamoto Y; Matsuda Y; Omae T; Takagi T; Ueda M
Biol Pharm Bull; 2021; 44(9):1286-1293. PubMed ID: 34471056
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing the use of opioids for breakthrough cancer pain: A secondary analysis of the IOPS-MS study.
Mercadante S; Adile C; Masedu F; Marchetti P; Costanzi A; Aielli F
Eur J Pain; 2019 Apr; 23(4):719-726. PubMed ID: 30421474
[TBL] [Abstract][Full Text] [Related]
9. [Oxycodone and pregabalin using transdermal fentanyl patch provided relief of symptoms for postherpetic neuropathic pain in a patient with non-small cell lung cancer].
Shibahara H; Ando A; Suzuki S; Uematsu N; Nishimura D
Gan To Kagaku Ryoho; 2011 Oct; 38(10):1675-7. PubMed ID: 21996965
[TBL] [Abstract][Full Text] [Related]
10. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
11. Opioid doses required for pain management in lung cancer patients with different cholesterol levels: negative correlation between opioid doses and cholesterol levels.
Huang Z; Liang L; Li L; Xu M; Li X; Sun H; He S; Lin L; Zhang Y; Song Y; Yang M; Luo Y; Loh HH; Law PY; Zheng D; Zheng H
Lipids Health Dis; 2016 Mar; 15():47. PubMed ID: 26952011
[TBL] [Abstract][Full Text] [Related]
12. Therapy switching in patients receiving long-acting opioids.
Berger A; Hoffman DL; Goodman S; Delea TE; Seifeldin R; Oster G
Ann Pharmacother; 2004 Mar; 38(3):389-95. PubMed ID: 14742831
[TBL] [Abstract][Full Text] [Related]
13. Only modest long-term opioid dose escalation occurs over time in chronic nonmalignant pain management.
Chapman CR; Bradshaw DH
J Pain Palliat Care Pharmacother; 2013 Dec; 27(4):370-7. PubMed ID: 24143927
[TBL] [Abstract][Full Text] [Related]
14. Dose and Duration of Opioid Use in Patients with Cancer and Noncancer Pain at an Outpatient Hospital Setting in Malaysia.
Zin CS; Rahman NA; Ismail CR; Choy LW
Pain Pract; 2017 Jul; 17(6):774-781. PubMed ID: 27676695
[TBL] [Abstract][Full Text] [Related]
15. Opioid Rotation in Cancer Pain Treatment.
Schuster M; Bayer O; Heid F; Laufenberg-Feldmann R
Dtsch Arztebl Int; 2018 Mar; 115(9):135-142. PubMed ID: 29563006
[TBL] [Abstract][Full Text] [Related]
16. Methadone is superior to fentanyl in treating neuropathic pain in patients with head-and-neck cancer.
Haumann J; Geurts JW; van Kuijk SM; Kremer B; Joosten EA; van den Beuken-van Everdingen MH
Eur J Cancer; 2016 Sep; 65():121-9. PubMed ID: 27494037
[TBL] [Abstract][Full Text] [Related]
17. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ
J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
[TBL] [Abstract][Full Text] [Related]
18. Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients.
Kannan TR; Saxena A; Bhatnagar S; Barry A
J Pain Symptom Manage; 2002 Jan; 23(1):60-5. PubMed ID: 11779670
[TBL] [Abstract][Full Text] [Related]
19. Fentanyl tolerance in the treatment of cancer pain: a case of successful opioid switching from fentanyl to oxycodone at a reduced equivalent dose.
Sutou I; Nakatani T; Hashimoto T; Saito Y
J Pain Palliat Care Pharmacother; 2015 Jun; 29(2):161-5. PubMed ID: 26095488
[TBL] [Abstract][Full Text] [Related]
20. Methadone versus Fentanyl in Patients with Radiation-Induced Nociceptive Pain with Head and Neck Cancer: A Randomized Controlled Noninferiority Trial.
Haumann J; van Kuijk SMJ; Geurts JW; Hoebers FJP; Kremer B; Joosten EA; van den Beuken-van Everdingen MHJ
Pain Pract; 2018 Mar; 18(3):331-340. PubMed ID: 28691202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
